The information contained in the Organizational Database (ODB) is provided for informational purposes only. There is no implied endorsement by NORD. NORD does not promote or endorse participation in any specific organization. The information is subject to change without notice. Every effort is made to ensure that the details for each entry are as current as possible.
55 Saw Mill Road
New City, NY 10956 USA
The GIST Cancer Research Fund (GCRF) was established in 2001 for the purpose of supporting and encouraging research on gastrointestinal stromal tumors (GIST), which belong to a group of cancers known as soft tissue sarcomas. GCRF also provides information on GIST and helps newly diagnosed patients learn about resources available to them. The number of new cases of GIST in the United States annually is estimated to be 5,000 to 6,000. Gastrointestinal stromal tumors arise in the intestinal tract, with the most common site being the stomach. GCRF provides information on GIST to patients, family members, the general public and the medical community. It conducts fundraising activities to support research related to the diagnosis and treatment of GIST. Other services include support groups and patient networking.
The National Organization for Rare Disorders (NORD) web site, its databases, and the contents thereof are copyrighted by NORD. No part of the NORD web site, databases, or the contents may be copied in any way, including but not limited to the following: electronically downloading, storing in a retrieval system, or redistributing for any commercial purposes without the express written permission of NORD. Permission is hereby granted to print one hard copy of the information on an individual disease for your personal use, provided that such content is in no way modified, and the credit for the source (NORD) and NORD’s copyright notice are included on the printed copy. Any other electronic reproduction or other printed versions is strictly prohibited.
NORD's Rare Disease Information Database is copyrighted and may not be published without the written consent of NORD.